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Temporal impact of sugar metabolism on the liver 
Ravi Chachad 
ABSTRACT 
Purpose: Increased sugar consumption is associated with metabolic conditions that can result in 
poor health outcomes. To investigate the impact of sugars such as glucose and fructose in the 
body, this study aims to determine the timing of effects and assess the impact of these effects. 
This study aims to demonstrate acute effects in metabolism as a result of sugar metabolism.  
Methods: Six male participants were imaged on a 3T MRI scanner at a fasted state then 
subsequently every hour for up to eight measurements. Between scanning sessions, they 
consume a 13C labeled glucose or fructose shake, have breath collected, and have blood drawn; 
this is repeated on a separate day to satisfy the other experimental condition. The MRI exam 
consists of Proton Density Fat Fraction (PDFF), proton Magnetic Resonance Spectroscopy (1H 
MRS), and 13C MRS. The images are processed to analyze liver volume and the spectra from the 
MR Spectroscopy are normalized and the peaks are quantified.  
Results: Liver volume is significantly different from baseline measurements at 2-, 3-, and 4-
hours post-feeding with p=0.032, p=0.003, and p=0.009 respectively. Fat content is significantly 
different from baseline measurements at 3- and 4-hours post-feeding with p=0.026 and p=0.048 
respectively. Different MR measures of fat fraction in the body produce a significant positive 
correlation (p=0.003). The median change of lipids (CH2) positively correlates with the median 
change in glycerol (p=0.011). Fat fraction does not significantly correlate with the blood 
measures taken, but when high choline and low choline groups are separated, new formed lipids 
in the blood and long-term storage of fat differ significantly, p=0.021 and p=0.03 respectively. 
 v 
Conclusions: Choline classification of participants resulted in a difference in new lipids in the 
blood and long-term storage in the liver. Low choline individuals tended to export less lipids in 
the blood and store more in the liver. High choline individuals exported more lipids and retained 
less in the liver. MR exams of the liver evaluate the health of the liver and burden to abdominal 
organs, whereas blood collection provided a glimpse into cardiovascular burden. 
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1     INTRODUCTION 
Sugars are consumed daily in a variety of foods. Increased consumption of sugars has 
been shown to incur deleterious health effects, promoting obesity, steatosis, diabetes and 
cardiovascular disease, while a reduction of sugars has been shown to have beneficial metabolic 
effects [1]. Two of the most commonly consumed sugars are glucose and fructose. Both are 
metabolized by the body in different ways; glucose is metabolized in various parts of the body 
and fructose is solely metabolized by the liver. Fructose has been suggested to be particularly 
damaging, in part due to its almost exclusive hepatic metabolism [2]. Fructose metabolism in 
excessive quantities can result in diabetes, obesity, and other health risks [3]. This can contribute 
to the increase of nonalcoholic fatty liver disease (NAFLD) which is proven to be associated 
with cardiovascular and metabolic complications [4]. Glucose when consumed stimulates insulin 
production that in causes cells to uptake glucose. In the liver, glucose is broken down into carbon 
dioxide and water, turned into glycogen, or converted in a series of other processes. Fructose 
undergoes processes where it can be broken down in cellular respiration, converted into 
glycogen, or used in the formation of fats. Fat accumulation in the liver can result in steatosis 
and a variety of other conditions that are associated with poor health outcomes and can be 
measured with Magnetic Resonance Imaging (MRI). MRI scanners manipulate a magnetic field 
in order to produce structural and functional images. Different tissues have different relaxation 
times which result in contrast to discriminate different physical structures. Fat can be 
discriminated in MRI and can be calculated using post-processing. Fats can also be exported out 
of the liver in the form of triglycerides and very-low density lipoprotein (VLDL). Triglycerides 
can be freely exported out of the liver and into the bloodstream whereas, VLDL is packaged in a 
vesicle. These vesicles are composed of the cell membrane which have phosphatidylcholine and 
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other phospholipids. To capture the metabolic fates of ingested fructose and glucose, blood 
measures can help quantify excreted fats, packaged as lipoproteins [5].  
 The purpose of the study was to evaluate the temporal effects of consuming glucose and 
fructose in the fasted state and determine their metabolic fates. To further studies to elucidate the 
roles of fructose and glucose, there is a need to understand their different metabolism and the 
timing of effects post consumption. Stable isotope labeled glucose and fructose can enable 
measurement of their metabolites with MR measures of liver volume providing indirect, further 
evidence of liver metabolism. Therefore, the goal of this study is to determine the timing and size 
of the metabolic fates of glucose and fructose post-feeding. The approach of this study is to 
evaluate subjects in a fasted state, then hourly, post-feeding with stable isotope labeled shakes, 
measuring excreted CO2, liver volume, liver fat fraction, 13C MR measured liver lipids, and 
lipoprotein measures in the blood.  
2     METHODS 
Six, non-diabetic male participants, who had fasted overnight, were studied on two 
separate days. Demographics and some body metrics related to body composition and insulin 
kinetics can be found in Table 1. This study measures the main metabolic fates of glucose and 
fructose in the breath, liver, and blood. The fates of interest are carbon dioxide, glycogen, 
triglycerides, and VLDL.  
Table 1: Demographics of study participants. Fat free mass and fat percentages were determined 
by Dual Energy X-ray Absorptiometry (DEXA). 
Participants (n=6) Mean  SD (Percentage) 
Age (yrs) 35.66  15.95 
Weight (kg) 110.54  17.29 
Body Mass Index (Kg/m2) 36.03  4.32 
Fat Free Mass (%) 67.82  8.51 
Fat (%) 38.00  6.14 
Homeostatic model assessment of Insulin 
Resistance (HOMA-IR) 
6.03  3.57 
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2.1     Study day 
One day participants received 13C-glucose labeled shakes after their fasted, baseline 
measures and repeatedly throughout the day and the other day they received 13C-fructose labeled 
shakes on the same schedule (Figure 1). The hourly measures taken include: CO2 collection via 
breath, Fat fraction (FF) by MR Spectroscopy (MRS), FF by Proton Density Fat Fraction 
(PDFF), liver volume based on PDFF images, fat and potentially other metabolites via 13C 
MRS, collection and DNL/VLDL production via blood draws and mass spectrometry analyses 
[6]. Each cycle lasts about one hour and the 3T MRI exam takes about 30 minutes to complete.   
 
Figure 1: Study day diagram with all measures. 
2.2     Carbon dioxide breath collection 
Carbon dioxide was collected after consuming the labeled shake. Participants exhaled 
into a vial using a straw which they slowly pulled out of the vial. Once the straw was no longer 
in the vial, a researcher quickly closed the vial and stored it for future analysis of the 13C 
enrichment of the expired CO2 which was labeled with, performed off-site at Metabolic 
Solutions, Inc. (Nashua, New Hampshire).    
2.3     Proton Density Fat Fraction (PDFF) 
Proton density fat fraction images were obtained through the liver (10mm slice 
thickness), using the Iterative Decomposition of water and fat with Echo Asymmetry and Least-
squares estimation (IDEAL) sequence acquired in one breath hold at end inspiration.  
2.4     Liver segmentation 
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Liver volumes were semi-automatically generated using an in-house, previously 
developed method incorporating the multiple images from the IDEAL sequence (R2*map, In-
phase image, and fat and water images). Automatic results sometimes included extrahepatic 
tissue, particularly if the subject had low levels of fat in the liver. These regions were manually 
identified and trimmed from the liver ROIs such as where the liver extended into the ribs, 
extended into the kidney, and included the heart and stomach (Figure 2). 
a)
 
b) 
 
Figure 2: Semi-automatic liver segmentation. a) Blue region indicates area perceived to be the 
liver after automatic segmentation is performed. b) After allowed manual edits are performed, 
the liver volume is corrected.  
 
2.5     MR Spectroscopy (1H MRS) 
Proton spectroscopy was obtained from a 20cc voxel in the liver, with TR/TE = 2500/30. 
Spectra were automatically phase-, frequency-, motion- and T2 relaxation-time corrected [7]. 
MR liver fat fractions were calculated from the corrected MR measures of CH2 and CH3 lipids 
and of water as the total lipids divided by total lipids and water. From the same spectra, a choline 
peak was quantified by calculating area under the peak and normalizing to the total lipids and 
water peak areas. 
2.6     Carbon-13 MR Spectroscopy (13C MRS) 
2.6.1     Acquisition 
13C MR spectroscopy was obtained using an in-house built receiver coil tuned to the 13C 
resonant frequency, placed on the patient’s right abdomen. Data was acquired both from a 
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selective pulse, localized to an oblique coronal plane (parallel to the coil) through the liver, 
excluding the subcutaneous fat. A selective pulse was used to acquire 384 acquisitions with 4096 
points and 10,000 Hz from a 40mm slab through the liver. 
2.6.2    Processing 
The 13C spectroscopy data was processed by performing an apodization and creating a 
level baseline. Under the long chain CH2 and CH3 lipid peak, there were broad peaks. These 
peaks were estimated using the points from both sides of the tails, outside the range of the 
higher, narrow peaks, to fit two Gaussian curves. The CH2 peak was used as the reference for all 
subsequent peak locations and was defined at 30.41ppm. The area of the fit for the CH3 peak had 
an amplitude limited to one-tenth that of the CH2 peak. These curves were subtracted to produce 
a flat baseline and to normalize data to compare between timepoints. An automatic method was 
also applied to the 13C MR spectra to identify the peaks of interest and report the area under the 
curve (Figure 3).  
 
 
 
 
Figure 3: 13C MRS Baseline Correction. Starts with the processed data (left), then fit two broad 
peaks. Subtract the broad peaks from the processed data and receive a spectrum with a new 
baseline (right). 
 
2.6.3    Quantification 
 Peaks are quantified by taking the area under the curve. The peaks of interest in this study 
were lipids (CH2) and glycerol (GLC). 
2.7     Blood draws 
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Blood draws were conducted hourly and were processed off-site at Touro University 
(Vallejo, California) using mass spectrometry. Blood is separated into four different samples: 
gold (8cc), grey (2cc), red (4cc), and purple (7cc). Gold samples are in serum-separating tubes 
(SSTs). Grey samples are processed with sodium fluoride and potassium oxalate. Red is 
processed with perchloric acid, and purple is processed with K2 EDTA. TG-Rich Lipoprotein 
(TRL) and VLDL were analyzed for percent DNL in those associated lipid compartments. 
Fractional DNL and precursor pool enrichments were measured by stable-isotope GC/MS-MIDA 
methodology [2]. 
2.8     Overall Analyses 
Measures at each timepoint were compared to baseline to determine any significant 
differences. Data was evaluated as change or percent change from baseline. Time courses were 
plotted to evaluate the change over the course of the day and significance of timepoints were 
determined. Different measures were correlated to identify connections between the multiple 
measures collected.  Statistical significance was determined by p<0.05. Statistical tests 
performed include Mann-Whitney U test, Cohen’s D for effect sizes, paired sample t-test, 
Pearson’s correlation, and Kendall correlation. Data when analyzed as a complete set can be 
analyzed using parametric tests due to the power reinforced by the number of measurements. 
When subletting data, non-parametric tests are used. Correlations for both a normal distribution 
and non-normal distribution were performed, Pearson correlation and Kendall correlation 
respectively.  
3     RESULTS 
3.1     Carbon dioxide through the day 
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 Exhaled carbon dioxide was collected post ingestion and the labeled carbon-13 carbon 
dioxide was quantified (Figure 4). The fructose day and glucose day carbon dioxide differed as 
more label appeared in the carbon dioxide produced on the fructose day when compared using a 
paired t-test of all the timepoints (p=0.0006). From the current data, when comparing fructose 
and glucose days, it can be anecdotally observed that carbon-13 that is incorporated into 
lipoproteins in the blood is detected earlier on the fructose day than on the glucose day.  
 
Figure 4: Change of labeled carbon dioxide exhaled in the breath. 
3.2     Liver volume through the day 
 For each participant, there was not a significant difference in their quantified liver 
volume on each study day (p=0.95). Due to the range of liver volumes in the study sample, liver 
volume was compared as a ratio to baseline (Figure 5). Some points through the day have a 
significantly different measurements than at baseline (Table 1).  
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Figure 5: Liver volume as a compared to baseline. Data is reported as median  SE (*p<0.05).  
 After using the semi-automatic method to obtain the liver volume, all the ROIs that 
compose the slices of the liver were analyzed. The fat fraction was the fat divided by fat plus 
water as generated by the scanner in the PDFF. To reduce the influence from noise or error due 
to visceral fat being segmented, the median fat fraction was used. Comparing the time course of 
fat fraction is a rough estimate of fat change throughout the course of the day as compared to 
baseline (Figure 6). 
 
Figure 6: Liver fat fraction as compared to baseline. Data is reported as median  SE (*p<0.05). 
 Total fat content is the product of liver volume and fat fraction. Comparing the time 
course of fat content is another estimate of fat change throughout the course of the day as 
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compared to baseline (Figure 7). This is a measure of how much fat is in the liver considering the 
amount of fat and water. The statistical significance between each time point through the day and 
baseline is listed in Table 2. 
 
Figure 7: Liver fat content as a compared to baseline. Data is reported as median  SE (*p<0.05). 
Table 2: Ratio of liver volume, fat fraction, and fat content in comparison to baseline. (*p<0.05, 
**p<0.01). 
8 am (Baseline) vs Liver volume Fat fraction Fat content 
10 am (r1) 0.976 1.049* 1.008 
11 am (r2) 0.948* 1.031 0.989 
12 pm (r3) 0.924** 1.015 0.957* 
1 pm (r4) 0.960** 1.013 0.968* 
2 pm (r5) 1.007 1.025 1.002 
3 pm (r6) 0.979* 1.081* 1.013 
4 pm (r7) 0.971 1.070* 1.074 
5 pm (r8) 0.977 1.081* 1.052 
3.3     Fat fraction comparison 
 Fat fraction is generated in the PDFF scans and through drawing ROIs encompassing the 
volume of the liver, the fat fraction of the liver is calculated. From the proton MRS, a fat fraction 
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is also calculated. These two values should correlate if the fat fraction in the voxel is 
representative of the fat fraction in the entire liver (Figure 8). 
 
Figure 8: Comparison of MRS fat fraction and calculated fat fraction from PDFF 
3.4     Composition of fat stored in the liver 
 CH2 lipids at the end of the day do not correlate with PDFF percentage while glycerol at 
the end of the day or with PDFF percentage (Figure 9). 
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b)  
Figure 9: Fat storage in the liver at the end of the day. in a) long hydrocarbon chains and b) 
glycerol molecules. 
 
 Median change in glycerol from the baseline to the end of the day is positively correlated 
with median change in long chain hydrocarbons from the baseline to the end of the day (Figure 
10). 
 
Figure 10: Correlation of median change of lipids. Lipid levels change over the course of the day 
as a result of feeding. 
 
3.5     Timing of newly formed 13C labeled lipids in the blood 
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 The first time at which lipids were detected in the blood from the mass spectrometry are 
noted in Table 4 along with time of maximum liver volume, maximum fat content, maximum 
glycerol amount, and maximum CH2 lipids. The blood measure noted was %DNL in VLDL. 
Participants with less than 3 blood samples are excluded from this table. There are no significant 
correlations between any of these factors and first quantification of blood sample.  
Table 3. Timing of blood and liver effects. 
Time of maximum 
liver volume 
Time of maximum 
fat content 
Time of maximum 
glycerol amount 
Time of maximum 
CH2 amount 
Time of first 
quantification of 
blood sample 
8 am 11am 10 am 5 pm 12 pm 
8 am 10 am 12 pm 5 pm 2 pm 
5 pm 5 pm 11 am 10 am 11 am 
5 pm 5 pm 4 pm 10 am 2 pm 
8 am 12 pm 2 pm 2 pm 1 pm 
8 am 4 pm 4 pm 5 pm 11 am 
11 am 5 pm 10 am 8 am 12 pm 
5 pm 4 pm 11 am 11 am 2 pm 
 
3.6     Export versus Storage 
 TRL and VLDL are both exported by the liver out into the body in an inverse relation to 
how much fat the liver itself did store; fractional DNL in these lipids are displayed in Figure 11. 
There is a moderate negative correlation (Pearson’s R2=0.32) between long-term fat storage and 
TRL and also with moderate negative correlation (Pearson’s R2=0.56) between long-term fat 
storage and VLDL. 
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a)  
b)  
 Figure 11: Correlation between fat fraction as a measure of long-term storage and lipid export 
into the blood. a) measured in TRL and b) measured in VLDL 
 
 The choline level of a participant is associated with their level of fat export and fat 
storage (Figure 12). Choline categorization of newly formed lipids in the blood is significant 
(p=0.021) as is the long-term storage of fats (p=0.03). In the Mann-Whitney U-test, U<5 is 
defined as significant; when grouped by high or low choline, newly formed lipids return a U-
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value of 1 and long-term fat storage returns a U-value of 4. A U-value indicates that values in 
one sample are larger than the other.  
a) 
 
b) 
 
Figure 12: Choline grouping to characterize storage and export of lipids. Choline is a factor in 
determining the fate of lipids in the body where a) exhibits the export component and b) exhibits 
the storage component. 
 
3.7     Correlations 
 The strength of correlations in previous sections is reported in Table 2. 
Table 4: Strength and significance of correlations. *p<0.05 
Variables correlated Correlation test Correlation Coefficient p-value 
Fat fraction vs MRS fat 
fraction 
Pearson 
correlation 
0.861 0.003* 
Fat fraction vs median 
change in 13C CH2 lipids 
Pearson 
correlation 
0.009 0.78 
Fat fraction vs median 
change in 13C glycerol 
Pearson 
correlation 
0.009 0.80 
Median change in CH2 lipids 
vs Median change in 
glycerol 
Pearson 
correlation 
0.729 0.011* 
Fat fraction vs %DNL in 
TRL 
Kendall 
Correlation 
0 1.000 
Fat fraction vs %DNL in 
VLDL 
Kendall 
Correlation 
-0.0667 0.861 
Choline vs Proton Density 
Fat Fraction 
Kendall 
Correlation 
-0.2121 0.381 
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4     DISCUSSION and CONCLUSION 
4.1     Breath interpretation 
 The 13C carbon dioxide metabolized from labeled fructose appears in the breath more 
than that from glucose. Both labeled molecules are metabolized which is a fate of both of these 
molecules and there are other fates which were measured [8]. The MRI and blood measures 
attempt to capture other intermediates and the metabolism. However, more carbon dioxide is 
formed as those products are broken down. Eventually, a steady state is metabolism will be 
reached since only so much catabolism occurs which creates carbon dioxide.   
4.2    Liver interpretation 
 Some studies do address the biases and corrections that are inherent with the 
quantification of the liver [9]. Liver volume loss from weight loss studies are a comparison of a 
pre and post diet; fluctuations in volume can be reported from a gain to a loss of about 5% [10]. 
Changes in liver volume of about 10% to 40% can be seen in dietary and pre-operative studies 
depending on intervention [11]. Liver volumes observed in the participant pool fluctuated about 
5% or more over the course of the day. Holistically observing the fat in an individual requires 
many different types of measurements at specific times. The liver volume and fat fraction can 
indicate different narratives of what is occurring in the body over time; fat content does combine 
this data to capture a more complete picture of fat in the liver. Liver volume decreases which 
could mean a loss of fat or glycogen, however, fat fraction increases which could be interpreted 
as an increase of fat. Fat content indicates the amount of fat and allows interpretation regardless 
of any other changes occurring in water or volume. Since the liver is highly vascularized, 
triglycerides in the liver are observed in the PDFF, 1H MRS, and 13C MRS scans.   
4.3     Blood interpretation 
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 By taking blood measures, fat that newly forms can be observed in the blood which is 
important to understand that a person may lack fat in their liver, but it could be circulating in 
their bloodstream.  
4.4     Fat export versus storage interpretation 
 Fat can be: metabolized, exported into the blood, or stored in the liver, in this study’s 
context. Choline does intertwine with lipoprotein vesicle formation which is the mechanism by 
which fat molecules can be exported. As a low choline diet results in liver damage and steatosis 
as a result of being unable to export fats, a balance of choline in the diet would be important to 
maintaining homeostasis between fat storage and fat export [12]. Each has an associated risk, 
therefore, managing intake would be important in determining health outcomes. Currently, it is 
unknown how to quantify an amount of choline needed to cause a specific effect and whether it 
is threshold-based or dose-dependent. With more research, the claim that high choline fraction is 
associated with less fat stored in the liver and that low choline fraction is associated with less 
export of fats into the blood could be substantiated. 
4.5     Segmentation 
 A semi-automatic approach needs to be employed since not enough data has been 
acquired for a fully automatic method; a semi-automatic method also results in less variability in 
quantification [13]. The segmentation struggles with organs that appear similarly in an MRI, thus 
creating larger compartments as it assumes all the pixels are part of the same structure. Since the 
final segmentations are modified, they do not suffer from this effect.  These results indicate that 
it is important to use the automatic section of this method to identify the clear borders of the liver 
and surrounding tissue and utilize manual segmentation to adjust organ interfaces.  
4.6     Peak quantification of 13C metabolites 
 17 
 The approach to quantify and normalize the 13C data visually flattened the baseline and 
allowed for comparison between the timepoints both in raw values and change over time. 
Differences in 13C metabolites to be quantified provides insight into how much of this isotope is 
retained in the liver in that timepoint. However, the new baseline is not perfect. It does 
standardize data, but it could be affecting the area under the peaks for other metabolites away 
from the CH2 peak. It is also possible that the constraints for the amplitude or location of the 
peaks may have been too rigid for some spectra and too relaxed for others. An increase in 13C 
glycerol being associated with an increase in 13C CH2 lipids can be due to the formation of 
triglycerides from these independent structures. For triglycerides to form, both of these 
compounds need to be present and a surplus of one compound could stimulate the production of 
the other to continue the storage of lipids in the liver [14]. In this method, glycerol was 
quantified, but it was not noted which pathway it had undergone to form glycerol; some 
processes are more direct whereas others are more time-consuming and have more intermediates 
[15]. Differences in these processes can result in additional variation due to multiple reactions 
potentially driving change in glycerol production over time. 
4.7    Limitations 
 The study consists of only six volunteers which is a low number of participants to recruit. 
However, the power is strengthened by the number of measurements taken since each participant 
is tested nine times including baseline and is studied on two days. While there is some 
dependence on some measures as they are conducted on the same individual, each MRI exam is 
independent since the participant is repositioned in the scanner every time. HOMA-IR refers to a 
measure of insulin resistance and sensitivity and by having different levels across the subjects, 
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metabolic pathways are impacted. Many pathways for consumed food are insulin dependent and 
the inability to respond or low sensitivity will elicit different responses [16]. 
 To accurately gauge fructose and glucose metabolism in the body, a day where only 
fructose and another with glucose respectively are served would provide a picture of what occurs 
in the body. In this study, the shakes consumed were composed of equal parts fructose and 
glucose but one of the two was labeled. However, a mixture of fructose and glucose is more 
representative of a typical diet; solely consuming one sugar may lead to a different metabolism, 
for example, more fructose may be converted into glucose. 
 Differences among the individuals does create variation in the data. Therefore, studying 
more individuals would create more confidence in the results obtained from the study. As many 
of these measures are continuous values, adding more subjects would add confidence in the 
values obtained and would strengthen correlation between metabolic events. Also, managing 
metabolic need impacts the study. Individuals who were fasted and received too many nutrients 
will elicit a different response than those who receive too few nutrients. Also, the timing of their 
effects may not accurately represent their normal metabolic state under nutritionally deprived or 
overfed conditions.   
4.8     Conclusion 
 In conclusion, this study of metabolic measures in a fasted state, then hourly, after hourly 
feeding, demonstrated some metabolic changes during the day: (1) fructose was metabolized into 
carbon dioxide significantly more than glucose; (2) liver volume was significantly lower at 2 and 
3 hours post feeding, then increased during the remainder of the day; (3) fat content in the liver 
was significantly lower 3 and 4 hours post feeding; (4) high choline individuals export more 
lipids into the blood; (5) low choline individuals store more fat in their liver. 
 19 
 The fact that liver volume significantly decreased when liver fat fraction significantly 
increased while the fat content remained stable suggests that the increase in fat fraction was due 
to the loss of water. Thus, it is recommended that both liver volume and fat fraction are 
determined before interpreting changes in fat fraction.   
 This study also demonstrated a number of differences among subjects, particularly in 
timing of changes during the course of the day, which may be due to different metabolic needs or 
other differences in metabolism. Further studies are required to elucidate these effects.  
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